Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 242 entries
View as:

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03411954 Org: User:
Start: 01/01/18 End: 03/31/22 Due: 03/31/23

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01175460 Org: User:
Start: 01/31/10 End: 01/31/11 Due: 01/31/12

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT05896059 Org: User:
Start: 05/15/23 End: 12/31/25 Due: 12/31/26

Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06704698 Org: User:
Start: 12/03/24 End: 12/30/25 Due: 12/30/26

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03647280 Org: User:
Start: 12/01/18 End: 09/30/20 Due: 09/30/21

CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02992067 Org: User:
Start: 04/30/15 End: 07/31/17 Due: 07/31/18

Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04790409 Org: User:
Start: 08/01/19 End: 09/13/23 Due: 09/13/24

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05903456 Org: User:
Start: 07/31/23 End: 12/31/25 Due: 12/31/26

Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01756183 Org: User:
Start: 09/30/11 End: 12/31/16 Due: 12/31/17

Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract

Phase: N/A Priority: Normal
NCT ID: NCT05794841 Org: User:
Start: 04/01/23 End: 03/31/25 Due: 03/31/26

Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01558947 Org: User:
Start: 01/31/11 End: 06/30/13 Due: 06/30/14

Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05448638 Org: User:
Start: 07/12/22 End: 08/05/23 Due: 08/05/24

The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy

Phase: N/A Priority: Normal
NCT ID: NCT05298319 Org: User:
Start: 04/01/22 End: 08/31/22 Due: 08/31/23

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT05557578 Org: User:
Start: 05/05/23 End: 12/31/25 Due: 12/31/26

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04974346 Org: User:
Start: 08/02/21 End: 08/01/30 Due: 08/01/31

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Phase: N/A Priority: Normal
NCT ID: NCT06046963 Org: User:
Start: 03/01/23 End: 03/31/25 Due: 03/31/26

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Phase: N/A Priority: Normal
NCT ID: NCT01158170 Org: User:
Start: 06/30/10 End: 12/31/13 Due: 12/31/14

3D Printed Models for Liver Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06006338 Org: User:
Start: 09/15/23 End: 02/29/24 Due: 02/28/25

Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03015727 Org: User:
Start: 12/31/16 End: 12/31/24 Due: 12/31/25

The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis

Phase: N/A Priority: Normal
NCT ID: NCT06861179 Org: User:
Start: 03/22/23 End: 12/28/24 Due: 12/28/25

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Phase: N/A Priority: Normal
NCT ID: NCT06214195 Org: User:
Start: 01/20/24 End: 12/01/30 Due: 12/01/31

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06422858 Org: User:
Start: 05/20/24 End: 04/30/26 Due: 04/30/27

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04119674 Org: User:
Start: 03/19/19 End: 08/23/22 Due: 08/23/23

Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study

Phase: N/A Priority: Normal
NCT ID: NCT05054166 Org: User:
Start: 05/01/21 End: 08/30/21 Due: 08/30/22

Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06861218 Org: User:
Start: 04/30/25 End: 12/31/28 Due: 12/31/29